Filing Flows › Comparisons › COSM vs STEK
Cosmos Health vs Stemtech: COSM and STEK compared
Cosmos Health is the larger company: $19.0M of revenue in its latest quarter (Q2 2026) against $629K for Stemtech (Q2 2026). Cosmos Health is growing faster (+29% against -10% a year earlier). Cosmos Health is more profitable, with an operating margin of -15.4% against -20.0%.
Where the money goes: COSM and STEK
Cosmos Health (COSM) · Q2 2026
Cosmos Health, Q2 2026: revenue $19.0M (+29% year over year), operating margin -15.4%, net loss $6.1M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Stemtech (STEK) · Q2 2026
Stemtech, Q2 2026: revenue $629K (-10% year over year), operating margin -20.0%, net loss $292K, operating cash flow −$55K. The chart follows the revenue to costs, profit and cash.
| Cosmos Health (COSM) | Stemtech (STEK) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $19.0M | $629K |
| Revenue growth, Y/Y | +29% | -10% |
| Operating margin | -15.4% | -20.0% |
| Net earnings | −$6.1M | −$292K |
| Net margin | -32.1% | -46.5% |
| Operating cash flow | −$1.7M | −$55K |
Questions
Which is bigger, Cosmos Health or Stemtech?
Cosmos Health is the larger company: $19.0M of revenue in its latest quarter (Q2 2026) against $629K for Stemtech (Q2 2026).
Is Cosmos Health or Stemtech growing faster?
Cosmos Health is growing faster (+29% against -10% a year earlier).
Which is more profitable, Cosmos Health or Stemtech?
Cosmos Health is more profitable, with an operating margin of -15.4% against -20.0%.
More: Cosmos Health earnings · how Cosmos Health makes money · Stemtech earnings · how Stemtech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 18, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.